{
    "nct_id": "NCT04180176",
    "official_title": "A Multicenter, Low-Interventional Study to Evaluate the Feasibility of a Prospective Clinicogenomic Program",
    "inclusion_criteria": "* Documented diagnosis of mNSCLC or ES-SCLC\n* Planned initiation of SOC systemic anti-cancer treatment\n* Front-Line Immunotherapy Cohort: Received front-line treatment of an immune blockade therapy including anti-CTLA-4, anti-PD-1, or anti-PD-L1 therapeutic antibody on Protocol GX41563\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "- Participant actively receiving investigational medicinal product(s) as part of an interventional trial at the time of signing informed consent",
    "miscellaneous_criteria": ""
}